Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Hoffmann-La Roche
Shukui Qin; Minshan Chen; Ann-Lii Cheng; Ahmed O Kaseb; Masatoshi Kudo; Han Chu Lee; Adam C Yopp; Jian Zhou; Lu Wang; Xiaoyu Wen; Jeong Heo; Won Young Tak; Shinichiro Nakamura; Kazushi Numata; Thomas Uguen; David Hsiehchen; Edward Cha; Stephen P Hack; Qinshu Lian; Ning Ma; Jessica H Spahn; Yulei Wang; Chun Wu; Pierce K H Chow; IMbrave050 investigators